advertisement
11.13.4 Betablocker and prostaglandin (6)
Showing records 1 to 6
Display all abstracts in classification 11.13.4 Betablocker and prostaglandin
Search within classification 11.13.4 Betablocker and prostaglandin49981 Topical prostaglandin fixed combinations in UK primary care: observational study using data from the health improvement network
Loftus J; Christopoulou D; Blak BT; Hards M
European Journal of Ophthalmology 2012; 22: 376-387
50378 Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy
Kashiwagi K
Japanese Journal of Ophthalmology 2012; 56: 339-345
50306 Assessment of ocular hypotensive effect and safety 12 months after changing from an unfixed combination to a latanoprost 0.005% + timolol maleate 0.5% fixed combination
Inoue K; Okayama R; Higa R; Wakakura M; Tomita G
Clinical Ophthalmology 2012; 6: 607-612
50528 Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
Inoue K; Fujimoto T; Higa R; Moriyama R; Kohmoto H; Nagumo H; Wakakura M; Tomita G
Clinical Ophthalmology 2012; 6: 771-775
50464 Efficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapy
Costa VP; Moreira H; Paolera MD; de Moraes Silva MR
Clinical Ophthalmology 2012; 6: 699-706
50570 Extended drug delivery by contact lenses for glaucoma therapy
Peng CC; Burke MT; Carbia BE; Plummer C; Chauhan A
Journal of Controlled Release 2012; 162: 152-158
